Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin vs Neomycin/Metronidazole for Gut Decolonisation in Colon Surgery
NCT07180615Phase 4Not yet recruiting
- Sponsor
- University of Lucerne
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in surgical site infection (SSI), sponsored by University of Lucerne. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
rifaximin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07180615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180615.